Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Apoptotic Potential and Chemical Composition of Jordanian Propolis Extract against Different Cancer Cell Lines

  • Abutaha, Nael (Bio-products Research Chair, Department of Zoology, College of Science, King Saud University)
  • Received : 2019.05.14
  • Accepted : 2019.11.21
  • Published : 2020.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

Propolis is a resinous substance that is collected by Apis mellifera from plant sources and is used in traditional medicine. To study the phytochemical constituents and apoptotic potential of Jordanian propolis extract against different cancer cell lines, propolis was extracted using methanol, hexane, and ethyl acetate and was fractionated using chromatographic methods. Cytotoxicity was assessed using MTT and LDH assays. The apoptotic potential was investigated using florescence microscopy, multicaspase assay, Annexin-V and dead cell assay, and cell cycle assay. The phytochemical constituents were analyzed using GC-MS. The methanol extract of propolis exhibited cytotoxic potential against all cell lines tested. The IC50 values of the methanol extract were 47.4, 77.8, 91.2, and 145.0 ㎍/ml for HepG2, LoVo, MDAMB231, and MCF7 cell lines, respectively. The IC50 values of the F1 fraction were 31.6 (MDAMB231), 38.9 (HepG2), 36.7 (LoVo) and 75.5 (MCF7) ㎍/ml. On further purification using thin-layer chromatography, the IC50 values of the F1-3 fraction were found to be 84.31(HepG2), 79.2 (MCF7), 70.4 (LoVo), and 68.9 (MDAMB231) ㎍/ml, respectively. The anticancer potential of the F1 fraction was confirmed through the induction of apoptosis and cell cycle arrest at the G0/G1 phase. The GC-MS analysis of the F1 fraction revealed the presence of 3-methyl-4-isopropylphenol (29.44%) as a major constituent. These findings indicate the potential of propolis extract as a cancer therapy. However, further investigation is required to assess the acute and subacute toxicity of the most active fraction.

Keywords

References

  1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. 2017. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 3: 524-548. https://doi.org/10.1001/jamaoncol.2016.5688
  2. Hassanpour SH, Dehghani M. 2017. Review of cancer from perspective of molecular. J. Cancer Res. Practice 4: 127-129. https://doi.org/10.1016/j.jcrpr.2017.07.001
  3. Khoja T, Zahrani A, Khoja TA. 2010. Epidemiology of cancer in the Gulf Region. Pan. Arab J. Oncol. 3.
  4. Jemal A, Center MM, DeSantis C, Ward EM. 2010. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19: 1893-1907. https://doi.org/10.1158/1055-9965.EPI-10-0437
  5. Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70: 461-477. https://doi.org/10.1021/np068054v
  6. Toreti VC, Sato HH, Pastore GM, Park YK. 2013. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid. Based Complement. Alternat. Med. 2013: 697390.
  7. Ebeid SA, El Moneim NAA, El-Benhawy SA, Hussain NG, Hussain MI. 2016. Assessment of the radioprotective effect of propolis in breast cancer patients undergoing radiotherapy. New perspective for an old honey bee product. J. Radiat. Res. Appl. Sci. 9: 431-440. https://doi.org/10.1016/j.jrras.2016.06.001
  8. Patel S. 2016. Emerging adjuvant therapy for cancer: propolis and its constituents. J. Diet. Suppl. 13: 245-268. https://doi.org/10.3109/19390211.2015.1008614
  9. Waly MI, Al Ajimi H, Al-Lawati HT, Guizani NI, Rahman SS. 2017. In vivo and In vitro evidence of anticancer effects of Omani propolis against colon cancer. FASEB J. 31: 790.722-790.722.
  10. Watanabe MAE, Amarante MK, Conti BJ, Sforcin JM. 2011. Cytotoxic constituents of propolis inducing anticancer effects: a review. J. Pharm. Pharmacol. 63: 1378-1386. https://doi.org/10.1111/j.2042-7158.2011.01331.x
  11. Pan L, Chai H, Kinghorn AD. 2010. The continuing search for antitumor agents from higher plants. Phytochem. Lett. 3: 1-8. https://doi.org/10.1016/j.phytol.2009.11.005
  12. Chan GC-F, Cheung K-W, Sze DM-Y. 2013. The immunomodulatory and anticancer properties of propolis. Clin. Rev. Allergy Immunol. 44: 262-273. https://doi.org/10.1007/s12016-012-8322-2
  13. Sawicka D, Car H, Borawska MH, Niklinski J. 2012. The anticancer activity of propolis. Folia Histochem. Cytobiol. 50: 25-37. https://doi.org/10.5603/FHC.2012.0004
  14. Lowe SW, Lin AW. 2000. Apoptosis in cancer. Carcinogenesis 21: 485-495. https://doi.org/10.1093/carcin/21.3.485
  15. Surh Y-J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 3: 768-780. https://doi.org/10.1038/nrc1189
  16. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407: 770. https://doi.org/10.1038/35037710
  17. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, et al. 2005. Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 46: 2035-2050.
  18. Aso K, Kanno S-i, Tadano T, Satoh S, Ishikawa M. 2004. Inhibitory effect of propolis on the growth of human leukemia U937. Biol. Pharm. Bull. 27: 727-730. https://doi.org/10.1248/bpb.27.727
  19. Almasan A, Ashkenazi A. 2003. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 14: 337-348. https://doi.org/10.1016/S1359-6101(03)00029-7
  20. Szliszka E, Czuba Z, Domino M, Mazur B, Zydowicz G, Krol W. 2009. Ethanolic extract of propolis (EEP) enhances the apoptosisinducing potential of TRAIL in cancer cells. Molecules 14: 738-754. https://doi.org/10.3390/molecules14020738
  21. Dziedzic A, Kubina R, Kabala-Dzik A, Tanasiewicz M. 2017. Induction of cell cycle arrest and apoptotic response of head and neck squamous carcinoma cells (Detroit 562) by caffeic acid and caffeic acid phenethyl ester derivative. Evid. Based Complem. Alternat. Med. 2017: 6793456.
  22. Weng M-S, Liao C-H, Chen C-N, Wu C-L, Lin J-K. 2007. Propolin H from Taiwanese propolis induces G1 arrest in human lung carcinoma cells. J. Agric. Food Chem. 55: 5289-5298. https://doi.org/10.1021/jf070201n
  23. Evan GI, Vousden KH. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342. https://doi.org/10.1038/35077213
  24. da Silva LM, Frion-Herrera Y, Bartolomeu AR, Gorgulho CM, Sforcin JM. 2017. Mechanisms involved in the cytotoxic action of Brazilian propolis and caffeic acid against HE p-2 cells and modulation of P-glycoprotein activity. J. Pharm. Pharmacol. 69: 1625-1633. https://doi.org/10.1111/jphp.12789
  25. Li H, Kapur A, Yang JX, Srivastava S, McLeod DG, Paredes-Guzman JF, et al. 2007. Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin. Int. J. Oncol. 31: 601-606.
  26. Motomura M, Kwon KM, Suh S-J, Lee Y-C, Kim Y-K, Lee I-S, et al. 2008. Propolis induces cell cycle arrest and apoptosis in human leukemic U937 cells through Bcl-2/Bax regulation. Environ. Toxicol. Pharmacol. 26: 61-67. https://doi.org/10.1016/j.etap.2008.01.008
  27. Chen J, Ni C, Zhang Z, Wang L, Liu Z, Peng W. 2018. GC-MS explores health care components in the extract of Pterocarpus Macarocarpus Kurz. Saudi J. Biol. Sci. 25: 1196-1201. https://doi.org/10.1016/j.sjbs.2017.12.013
  28. Gao W, Wang Y, Wang W, Shi L. 2017. The first multiplication atom-bond connectivity index of molecular structures in drugs. Saudi Pharm. J. 25: 548-555. https://doi.org/10.1016/j.jsps.2017.04.021
  29. Mijangos-Ramos IF, Zapata-Estrella HE, Ruiz-Vargas JA, Escalante-Erosa F, Gomez-Ojeda N, Garcia-Sosa K, et al. 2018. Bioactive dicaffeoylquinic acid derivatives from the root extract of Calea urticifolia. Rev. Bras. Farmacogn. 28: 339-343. https://doi.org/10.1016/j.bjp.2018.01.010
  30. Marcucci M. 1995. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26: 83-99. https://doi.org/10.1051/apido:19950202

Cited by

  1. S-phase cell cycle arrest, and apoptotic potential of Echium arabicum phenolic fraction in hepatocellular carcinoma HepG2 cells vol.34, pp.1, 2020, https://doi.org/10.1016/j.jksus.2021.101735